Exelixis, Inc. provided earnings guidance for the fiscal year 2024. For the year, company expects Total revenues to be $1,825 million - $1,925 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.96 USD | -0.86% |
|
-2.53% | -8.46% |
Jul. 04 | ANALYST RECOMMENDATIONS : Citigroup, Constellation Brands, Broadcom, JPMorgan, Bunzl... | ![]() |
Jul. 02 | Ipsen Expands Partnership with Exelixis for Cabometyx | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.46% | 6.4B | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.02% | 25.98B | |
-24.33% | 19.27B | |
-18.79% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis, Inc. Provides Earnings Guidance for Fiscal Year 2024